Please provide your email address to receive an email when new articles are posted on . Pivmecillinam was approved for uncomplicated urinary tract infections for women. Pivmecillinam led to higher ...
This guide deconstructs the pathophysiology of UTIs, exploring the anatomical risks in women, and the efficacy of antibiotic ...
On Friday, Iterum Therapeutics plc (NASDAQ:ITRM) received FDA approval for its Orlynvah (sulopenem etzadroxil and probenecid) for uncomplicated urinary tract infections (uUTIs) caused by the ...
DUBLIN and CHICAGO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (ITRM) (Iterum), today announced that the U.S. Food and Drug Administration (FDA) has approved Iterum’s new drug ...
DUBLIN and CHICAGO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by ...
A team of researchers led by microbiologist Professor Dr. Axel Hamprecht of the University Medicine Oldenburg has developed a new method that enables quicker detection of a frequently overlooked ...
All of this disproportionately affects the elderly. In a 2023 study of patients with a median age of 75, approximately 30% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback